Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare Ltd's Board of Directors, at a meeting held on March 16, 2026, approved three key management appointments effective the same day. Ms. Kalyani Vijay Chordia, a Chartered Accountant, was appointed as the new Chief Financial Officer in the Key Managerial Personnel category. Additionally, Mr. Chirag Mehta (a pharma executive with 25+ years of experience) was named Head-Operations, and Mr. Ravikant Chavan (an IT professional with 12+ years of experience) was appointed as IT-Head, both under Senior Management Personnel. All three appointments were made on the recommendation of the Nomination and Remuneration Committee, and none of the appointees are related to any existing Director on the Board.
These appointments strengthen the company's leadership bench across finance, operations, and technology, which could support execution and compliance going forward. For shareholders, the move signals active management restructuring, but the stock impact is likely to be neutral in the short term since these are fresh additions rather than response to any crisis.